Redeye: Hoylu - Continued ARR growth
Redeye makes slight forecast adjustments following Hoylu’s Q3 2022 report. The ARR amounted to SEK50m in the quarter, being already known thanks to its monthly ARR reporting, while the cost-side came in largely as expected. Overall, it gives rise to minor changes in our valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.